Analysts' Actions: CCMP CPN JBHT KNX WM

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Bunge Ltd. (BG) was upgraded to buy at TheStreet Ratings.

Cabot Microelectronics (CCMP) was upgraded at DA Davidson to buy from neutral. Twelve-month price target is $50. Company could be a takeover target, DA Davidson said.

Calpine (CPN) was downgraded at UBS to neutral from buy. There are few catalysts, with capacity in Texas down and limited EBITDA growth in California, UBS said. Twelve-month price target is $22.

Dresser-Rand (DRC) was downgraded at Morgan Stanley to equal-weight. Twelve-month price target is $57. Slower infrastructure spending is hurting profits, Morgan Stanley said.

International Game Technology (IGT) was downgraded to hold at TheStreet Ratings.

JB Hunt (JBHT) was upgraded at Wunderlich to buy from hold. Twelve-month price target is $89. New analyst believes that margins can expand, Wunderlich said.

Knight Transportation (KNX) was downgraded at Wunderlich to hold from buy. New analyst believes the stock is fully valued, based on a 12-month price target of $25.

SolarCity (SCTY) was downgraded at Robert Baird to neutral from outperform. Valuation call, Baird said.

SM Energy (SM) was downgraded at Keybanc to hold. Company is seeing lower crude production, Keybanc said.

Scripps (SNI) was upgraded at Argus to buy from hold. Twelve-month price target is $100. HGTV and Food Channel remain key growth drivers, Argus said.

Waste Management (WM) was downgraded at Wunderlich to hold from buy. WTE and recycling will remain a drag on growth, Wunderlich said.


Stock Comments / EPS Changes

Analog Devices (ADI) price target, EPS estimates were lifted at UBS. Driven by solid execution and seasonal demand trends, UBS said. Twelve-month price target is $52. Neutral rating.

BioMarin Pharma (BMRN) price target was lifted at Jefferies. Valuation call driven by success of 3 Ph3 products, Jefferies said. Twelve-month price target is $87. Buy rating.

Cardinal Health (CAH) numbers were boosted at Credit Suisse. Twelve-month price target is now $80. Estimates were also increased, given the company's new guidance, Credit Suisse said. Outperform rating.

Colgate (CL) estimates, price target were reduced at BMO Capital. Twelve-month price target is now $64. Estimates were also cut, given currency rates, BMO Capital said. Market Perform rating.

Dollar General (DG) numbers were cut at BMO Capital. Estimates were reduced through 2015. Company could face increased competition from Wal-Mart WMT. Outperform rating and new $65 price target.

Fluor (FLR) 12-month price target was lifted at Jefferies. O&G remains the growth driver, Jefferies said. Twelve-month price target is $95. Buy rating.

General Dynamics (GD) price target, EPS estimates were lifted at UBS. Twelve-month price target is now $118, UBS said. Driven by raised estimates in Saudi and share repo opportunity, UBS said. Estimates were increased through 2015. Buy rating.

Genesis Energy (GEL) price target was increased at UBS. Driven by higher cash flows for Baton Rouge project and increasing Marin and Offshore pipeline volumes, UBS said. Twelve-month price target is $60. Buy rating.

Illumina (ILMN) price target, EPS estimates were increased at UBS. Demand momentum and competitive position appear stronger than ever, UBS said. Twelve-month price target is $202. Buy rating.

Jack in the Box (JACK) price target, EPS estimates were increased at Jefferies. Accelerating sales and margin, combined with cost synergies, should increase operating results, Jefferies said. Twelve-month price target is $62. Buy rating.

Coca-Cola (KO) numbers were cut at Credit Suisse. Twelve-month price target is now $46. Estimates were also reduced, given challenging top-line growth and currency trends, Credit Suisse said. Outperform rating.

Priceline.com (PCLN) estimates, price target were increased at Jefferies. Stable growth in the Americas and improvement in Europe, Jefferies said. Twelve-month price target is $1,475. Buy rating.

Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

More from Stocks

Never Buy Stocks Based on Unusual Call Activity: Doug Kass Insider

Never Buy Stocks Based on Unusual Call Activity: Doug Kass Insider

Will Tesla Stock Tumble 33% to $195?

Will Tesla Stock Tumble 33% to $195?

Is Best Buy Sleeping With the Enemy With Amazon Partnership?

Is Best Buy Sleeping With the Enemy With Amazon Partnership?

Video: The S&P 500 Is Failing to Make New Highs

Video: The S&P 500 Is Failing to Make New Highs

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump